Original Source: Electroactive Polymers

Buy Now: Electroactive Polymers

Report description

Technological developments in the electronics and semiconductor industries have led to the creation of polymers that change shape on the application of voltage. The biggest application for electroactive polymers (EAPs) lies in their future use as actuators and sensors, which in turn opens up a huge spectrum of applications in the fields of electronics, healthcare, sensing, and solar energy generation. With the growing market for each of these applications, EAP is set to become a mainstream market in the next five years. However, the technical specifications for each application differ widely, and extensive research and investments are still needed for developing application-specific EAPs.

The global electroactive polymers product market is expected to be worth US$2.78 billion by 2014. The conductive plastics segment contributed 84% to the overall market in 2009, mainly due to its extensive application in electrostatic discharge and electromagnetic interference. As the EAP market is still in the early phase, it presents many advantages for the early movers. As there are not too many companies involved now, detailed knowledge of the competitors will be crucial for the success of each company.

Scope of the report

This report aims to identify and analyze products and applications that use electroactive polymers. The report has segmented the global electroactive polymers market as follows:

• Electroactive Polymers Product Market: Conductive plastics, Inherently Conductive Polymers (IDPS) and Inherently Dissipative Polymers (IDPS)
• Electroactive Polymers Applications Market: OLED, Capacitors, Batteries, Organic transistors, Sensors, Solar cells, Actuators, Textiles and fabrics, Electromagnetic interference (EMI), Electrostatic discharge (ESD), Antistatic packaging, Paints and coatings and others.
• Electroactive Polymers Technology Market: ICPs doping technology, Benefits of ICPs and technical aspects of conductive plastics

Each section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report will also provide more than 45 market tables for various geographic regions covering the sub-segments and micro-markets. In addition, the report also provides more than 30 company profiles for each of its sub-segments.

What makes our reports unique?

• We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5.
• Each report is about 250 pages with 100+ market data tables, 40 competitive company profiles, analysis of 300 patents and a minimum of 50 micro markets, which are collectively exhaustive and mutually exclusive.
• No single report by any other publisher provides market data for all the segments viz products, services, applications, ingredients, technology, and stakeholders in a single report for all the four geographies – US, Europe, APAC, RoW.
• We provide 10% customization. Normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.
• 15 pages of high level analysis including benchmarking strategies, best practices and the market’s cash cows (BCG matrix). We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.
• Comprehensive market analysis for the following sectors: Pharmaceuticals, medical devices, biotechnology, semiconductor and electronics, energy and power supplies, food and beverages, chemicals, advanced materials, industrial automation, and telecom and it. we also analyze retailers and super-retailers, technology providers, and research and development (R&D) companies.

Key questions answered

• Which are the high-growth segments/cash cows and how is the market segmented in terms of applications, products, services, ingredients, technologies, and stakeholders?
• What are market estimates and forecasts; which markets are doing well and which are not?
• Where are the gaps and opportunities; what is driving the market?
• Which are the key playing fields? Which are the winning edge imperatives?
• How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?

Powerful Research and analysis

The analysts working with MarketsandMarkets come from renowned publishers and market research firms, globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We, at MarketsandMarkets, are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.

Original Source: Electroactive Polymers

Buy Now: Electroactive Polymers

Table of Contents

1. Introduction

2. Summary

3. Market Overview
3.1. Market definition
3.2. Evolution of Electro-active Polymers
3.3. Comparison of Electro-active Polymers with other competing materials

4. Types of Electro-active Polymers
4.1. Inherently Conductive Polymers (ICPS)
4.1.1. Types of ICPS
4.1.1.1. Polythiophenes
4.1.1.2. Polyanilines
4.1.1.3. Polypyrroles
4.1.1.4. Polyacetylenes
4.1.1.5. Polyphenylene Vinylene
4.1.1.6. Polyfluorenes
4.1.1.7. Polyphenylene Sulfide
4.1.1.8.Polynaphthalene
4.1.2. Doping Technologies for ICPS
4.1.2.1. Chemical
4.1.2.2. Electrochemical
4.1.2.3. Types of dopants
4.1.3. Technical aspects of ICPS
4.1.3.1. Molecular weight
4.1.3.2. Improvement of high temperature conductivity and thermal stability
4.1.3.3. Alloys and Blends of ICPS with resins
4.1.4. Benefits of ICPS
4.1.4.1. Conductivity
4.1.4.2. Electro-chromic effects
4.1.4.3. Electroluminescence
4.1.4.4. Photoconductivity
4.1.4.5. Thermo-chromic effects
4.2. Inherently Dissipative Polymers (IDPS)
4.3. Conductive Plastics
4.3.1. Types of Conductive Plastics
4.3.1.1. ESD/EMI Compounds
4.3.1.2. Antistatic Additives
4.3.1.3. Metal/carbon Fibers
4.3.1.4. Carbon Nanotubes
4.3.2. Technical aspects of Conductive Plastics
4.3.2.1. Blends of conductive plastics and powder coatings
4.3.2.2. Novel conductive additives
4.4. Others

5. Electrical configuration
5.1. Dielectric
5.2. Ionic

6. Major role applications
6.1. Actuators
6.2. Sensors

7. End-Applications of Electro-active Polymers
7.1. Light Emitting Diode
7.2. OLED
7.3. Capacitors
7.4. Batteries
7.4.1. Lithium Batteries
7.4.2. All-polymer battery
7.4.3. Button Battery
7.4.4. Automotive battery
7.4.5. Portable computer battery
7.5. Semiconductor Transistors
7.5.1. Silicon substrates
7.5.2. Organic/Plastic transistors
7.6. Sensors
7.6.1. Remotely readable sensors
7.6.2. Gas sensors
7.6.3. Odor sensors
7.6.4. Chemical sensors
7.6.5. Biosensors
7.7. Solar Cells
7.8. Electronic displays
7.8.1. Flat panel displays
7.8.2. CRT
7.9. Electromagnetic interference
7.10. Electrostatic discharge
7.11. Antistatic packaging
7.12. Plastics coated with electrostatic paints
7.13. Other upcoming applications

8. Geographic analysis
8.1. United States
8.2. Europe
8.3. Asia

9. Company Profiles
9.1. BTech Scientific
9.2. Agfa-Gevaert NV
9.3. Air Products & Chemicals
9.4. American Dye Source
9.5. BASF, Inc
9.6. Cambridge Display Technology
9.7. Central Corporation
9.8. Crosslink Polymer Research
9.9. Dupont Displays
9.10. Eeonyx
9.11. Fractal Systems
9.12. Kemet Capacitors
9.13. Klockner Pentaplast of America
9.14. LNP Engineering Plastics
9.15. Lubrizol Advanced Materials
9.16. Marktek, Inc
9.17. Merck KGAA-Darmstadt
9.18. Milliken Research Corporation
9.19. Nanogenesys
9.20. Ormegon Chemie
9.21. Panipol Ltd
9.22. Plastic Logic
9.23. Plextronics, Inc
9.24. Polymer Vision, Ltd
9.25. Polyone
9.26. Premix OY
9.27. Rieke Metals
9.28. RTP Company
9.29. H.C. Starck International
9.30. Sterling Fibers
9.31. Universal Display Corporation

10. Patents
10.1. U.S Patents
10.2. Europe Patents
10.3. Asia Patents

Original Source: Electroactive Polymers

Buy Now: Electroactive Polymers

Global Electroactive Polymers Market: Revolutionizing Automation World

The increasing need for greater sophistication in the automation industry and in electronics protection is driving the market for low-cost, lightweight, and low driving voltage materials. Advances in electronics and polymers manufacturing technology have given rise to the concept of electroactive polymers. These polymers began to be used as base materials for motion control and protective applications as the use of mechanical moving parts reduced efficiency and increased wear and tear. When compared with conventional motion-generating devices, electroactive polymers provide equally good efficiency and lower costs and power consumption.

The electroactive polymers market is segmented into conductive plastics, inherently conducting polymers and inherently dissipative polymers. The global electroactive polymers market was at $1.7 billion in 2008; and is expected to grow exponentially at a CAGR of 8.3% from 2009 to 2014 mainly due to the already existing demand for new applications be commercialized in the next five years.

The electroactive polymers market holds a lot of scope for improved material commercialization as it is still in its nascent stage, and as high temperature resisting polymers are yet to be developed. The expected applications of electroactive polymers, such as full-page displays and biomimetics, are expected to boost the overall market. The development and commercialization of new polymers would further widen EAP applications. The key players in the electroactive polymers market include Artificial Muscle, H.C. Starck, Panipol Oy, etc.

Intensive R&D efforts, early product commercialization, and the high absorption rate of electronic products made North America the dominant market in 2008. The region held a 64% share of the global electroactive polymers product market, followed by Europe with a 22% share in the same year.

Global Electroactive Polymers Market by Products, 2009

Source: MarketsandMarkets

In 2009, the conductive plastics submarket is expected to dominate the global electroactive polymers market with 84% share, mainly due to its extensive application in electrostatic discharge and electromagnetic interference.

The U.S. accounted for 41% of the total number of electroactive polymers patents filed worldwide between 2004 and September 2009. The region had the highest number of patents mainly due to the presence of major players in this region and increasing R&D for new applications.

Our analysis indicates that companies taking the first mover advantage by quick commercialization of applications with intensive R&D efforts for new polymers and applications will have an edge over their competitors. Agreements and collaborations as well as new product launches are some of the most popular strategies adopted by market players to stay ahead of the competition and to expand into new geographies.

Original Source: Electroactive Polymers

Buy Now: Electroactive Polymers

 

Table of Content

1. Introduction

2. Summary

3. Market Overview

3.1. Market definition

3.2. Evolution of Electro-active polymers

3.3. Comparison of Electro-active polymers with other competing materials

3.4. Driving factor analysis of EAP market

3.5. Relative potential matrix for EAP products

3.6. Global EAP market dynamics

4. Types of Electro-active Polymers

4.1. Inherently Conductive Polymers (ICPS)

4.1.1. Types of ICPS

4.1.1.1. Polythiophenes

4.1.1.2. Polyanilines

4.1.1.3. Polypyrroles

4.1.1.4. Polyacetylenes

4.1.1.5. Polyphenylene Vinylene

4.1.1.6. Polyfluorenes

4.1.1.7. Polyphenylene Sulfide

4.1.1.8. Polynaphthalene

4.1.2. Doping Technologies for ICPS

4.1.2.1. Chemical

4.1.2.2. Electrochemical

4.1.2.3. Types of dopants

4.1.3. Technical aspects of ICPS

4.1.3.1. Molecular weight

4.1.3.2. Improvement of high temperature conductivity and thermal stability

4.1.3.3. Alloys and Blends of ICPS with resins

4.1.4. Benefits of ICPS

4.1.4.1. Conductivity

4.1.4.2. Electro-chromic effects

4.1.4.3. Electroluminescence

4.1.4.4. Photoconductivity

4.1.4.5. Thermo-chromic effects

4.2. Inherently Dissipative Polymers (IDPS)

4.3. Conductive Plastics

4.3.1. Types of Conductive Plastics

4.3.1.1. ESD/EMI Compounds

4.3.1.2. Antistatic Additives

4.3.1.3. Metal/carbon Fibers

4.3.1.4. Carbon Nanotubes

4.3.2. Technical aspects of Conductive Plastics

4.3.2.1. Blends of conductive plastics and powder coatings

4.3.2.2. Novel conductive additives

5. Electrical configuration

5.1. Dielectric

5.2. Ionic

6. Applications of Electro-active Polymers

6.1. OLED

6.2. Capacitors

6.3. Batteries

6.3.1. Lithium Batteries

6.3.2. All-polymer battery

6.3.3. Button Battery

6.3.4. Automotive battery

6.3.5. Portable computer battery

6.4. Semiconductor Transistors

6.4.1. Silicon substrates

6.4.2. Organic/Plastic transistors

6.5. Sensors

6.5.1. Gas sensors

6.5.2. Odor sensors

6.5.3. Chemical sensors

6.5.4. Biosensors

6.6. Solar Cells

6.7. Actuators

6.8. Electronic displays

6.8.1. Flat panel displays

6.8.2. CRT

6.9. Electromagnetic interference

6.10. Textiles and Fabrics

6.11. Electrostatic discharge

6.12. Antistatic packaging

6.13. Plastics coated with electrostatic paints

6.14. Other upcoming applications

7. Geographic analysis

7.1. North America

7.2. Europe

7.3. Asia

7.4. RoW

8. Company Profiles

8.1. 3M

8.2. Abtech Scientific, Inc.

8.3. Agfa-Gevaert Group NV

8.4. American Dye Source, Inc.

8.5. Artificial Muscle

8.6. BASF, Inc

8.7. Beakert

8.8. Cabot Corporation

8.9. Cambridge Display Technology

8.10. Central Corporation

8.11. Chevron Philips

8.12. Cytec Industries Inc.

8.13. Danfoss

8.14. Discover Technologies Inc.

8.15. Eamex

8.16. Eeonoyx

8.17. Fractal System, Inc.

8.18. H.C. Starck International

8.19. Hyperion Catalysis International, Inc.

8.20. Kemet Corporation

8.21. Konarka Technologies, Inc.

8.22. Lubrizol Advanced Materials

8.23. Marktek

8.24. Medipacs LLC

8.25. Micromuscle AB

8.26. Ormegon Chemie

8.27. Panipol Ltd

8.28. Plextronics, Inc

8.29. Polyone

8.30. Premix OY

8.31. Rieke Metals, Inc

8.32. Rtp company

9. Patents

9.1. U.S. Patents

9.2. Europe Patents

9.3. Asia Patents

10. Appendix

Original Source: wireless backhaul equipment market

Buy Now: wireless backhaul equipment market

The improvements in networking and modern-day communications have brought about the demand for bulk transfer of voice and data from one point separated from another by almost 50-100 miles. While the conventional wire-connected networks had great bandwidth, they involved the complex task of the stretching physical wires over great distances. In wireless data backhaul, data packets can be sent to distances as far as 50 miles at a speed ranging from 1Mbps to 2Gbps. Cellular operators have played an important role in this new emerging market of wireless data backhauling. The emergence of 3G services has provided biggest market boost, as these services provide organizations huge bandwidth for transferring data from one location to another.

The growing trend of globalization has been a pivotal factor in the market growth of telecommunications; and thus acts as a market driver for wireless data transfer and the wireless backhaul market as well. The economic growth of developing nations and the spread of internet and mobile communications in these regions have opened up new markets for wireless backhauling. The market is set for a huge growth as wireless backhaul is expected to become a mainstream technology for data transfer within the next five years.

The global wireless and mobile backhaul equipment market is expected to be worth US$38.0 billion by 2014, growing at an estimated CAGR of 18.7% from 2009 to 2014. Microwave forms the largest market segment and is expected to reach a size of US$16.5 billion by 2014. Asia is the largest wireless backhaul market; and is expected to be worth US$12.2 billion by 2014, accounting for nearly 32% of the total revenues. The Asian wireless backhaul market also has the highest CAGR of 21.8%.

Scope of the Report

This report aims to identify and analyze Global Wireless and Mobile Backhaul Equipment Market according to applications, technologies, and topologies. The report provides in-depth market estimates and forecasts for Global Wireless and Mobile Backhaul Equipment Market as follows:

• Wireless and Mobile Backhaul Equipment Market– Technologies: TDM & ATM, microwave, pseudowire, free space optics, satellite, All-IP RAN
• Wireless and Mobile Backhaul Equipment Market– Application: Voice/data backhaul between cellular towers, broadband backhaul connectivity, building-to-building connectivity, video surveillance backhaul
• Wireless and Mobile Backhaul Equipment Market– Topologies: Point to Point (PTP) configurations, Point to Multipoint (PTM) configurations, wireline bridging and extension

Each section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report will also provide various market tables for different geographic regions covering the sub-segments and micro-markets. In addition, the report also provides 40 company profiles for each of its sub-segments.

What makes our reports unique?

• We provide the longest market segmentation chain in this industry- not many reports provide market breakdown up to level 5.
• Each report is about 250 pages with 50+ market data tables, 40 competitive company profiles, analysis of 300 patents and minimum 50 micro markets, which are collectively exhaustive and mutually exclusive.
• No single report by any other publisher provides market data for all the segments viz products, services, applications, ingredients, technology, and stakeholders in a single report for all the four geographies – US, Europe, APAC, ROW.
• We provide 10% customization- normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.
• 15 pages of high level analysis including benchmarking strategies, best practices and the market’s cash cows (BCG matrix). We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.

Key questions answered

• Which are the high-growth segments/cash cows and how is the market segmented in terms of applications, products, services, ingredients, technologies, stakeholders?
• What are market estimates and forecasts; which markets are doing well and which are not?
• Where are the gaps and opportunities; what is driving the market?
• Which are the key playing fields? Which are the winning edge imperatives?
• How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?

Powerful Research and analysis

The analysts working with MarketsandMarkets come from renowned publishers and market research firms, globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We, at MarketsandMarkets, are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.

Original Source: wireless backhaul equipment market

Buy Now: wireless backhaul equipment market

Table of Contents

1. Introduction

2. Summary

3. Market Overview
3.1. Evolution of wireless backhaul
3.2. Impact analysis of affecting factors
3.3. Growing trends of 3G subscribers

4. Transport mechanisms for wireless backhaul
4.1. TDM Leased Lines
4.2. Microwave
4.3. All-IP RAN
4.4. Satellite
4.5. Multi-service systems using pseudo-wires
4.6. Free space optics
4.7. Asynchronous transfer mode (ATM)
4.8. Others

5. Network topologies for Backhaul
5.1. Point to point (PTP) configurations
5.2. Point to multipoint (PTM) configurations
5.3. Wireline bridging and extension
5.4. Comparative analysis
5.4.1. Operational cost comparison for PTP, PTM and wireline
5.4.2. Capital cost comparison for PTP, PTM and wireline
5.4.3. Performance comparison for PTP, PTM and Wireline
5.4.3.1. Bandwidth capacity
5.4.3.2. Reliability

6. Wave properties
6.1. Modulation
6.1.1. Phase-shift keying (PSK) modulation
6.1.2. Quadrature amplitude (QAM) modulation
6.2. Multiplexing
6.2.1. Frequency division multiplexing (FDM)
6.2.2. Time division multiplexing (TDM)
6.2.3. Orthogonal frequency division multiplexing ( OFDM)

7. Wireless backhaul- A challenging market for cellular operators
7.1. Increase in 3G service for backhaul
7.2. Reduction in cost per bit
7.3. Reduction in profitability
7.4. Challenges in maintaining operational cost
7.5. Challenge from the DSL service operators
7.6. Emerging threat from IP/Ethernet
7.7. Growing popularity of satellite backhaul
7.8. Limited spectrum availability for wireless backhaul

8. Applications
8.1. Voice/data backhaul between cellular towers
8.2. Broadband backhaul connectivity
8.3. Building-to-building connectivity
8.4. Video surveillance backhaul

9. Geographic Analysis
9.1. United States
9.2. Europe
9.3. Asia

10. Company Profiles
10.1. AT&T
10.2. Qwest
10.3. Verizon
10.4. Embarq
10.5. Windstream
10.6. Cox Communications
10.7. Time Warner Cable
10.8. Optimum Lightpath
10.9. Bright House Networks
10.10. Comcast
10.11. Charter
10.12. TW telecom
10.13. XO Communications
10.14. Level 3
10.15. Nortel
10.16. ADC Telecommunications
10.17. Sumitomo Electric Lightwave
10.18. ZTE Corporation
10.19. Harmonic
10.20. Shanghai Sun Telecom
10.21. Polatis
10.22. Diamond USA
10.23. Cisco Systems
10.24. Commscope
10.25. Anritsu
10.26. Cable Plus, LLC
10.27. LightComm Technology
10.28. Volex
10.29. Sunrise Opto Limited
10.30. Absolute Analysis
10.31. FiberTower

11. Patents
11.1. U.S Patents
11.2. Europe Patents
11.3. Asia Patents

Original Source: wireless backhaul equipment market

Buy Now: wireless backhaul equipment market

Immense Opportunities in the Global Wireless and Mobile Backhaul Equipment Market

The growing trend of globalization has been a pivotal factor in the market growth of telecommunications; and thus acts as a market driver for wireless data transfer and the wireless backhaul market as well. The economic growth of developing nations and the spread of internet and mobile communications in these regions have opened up new markets for wireless backhauling. The market is set for a huge growth as wireless backhaul is expected to become a mainstream technology for data transfer within the next five years.

The global wireless and mobile backhaul equipment market is getting a boost mainly from the increasing adoption of third generation (3G) and fourth generation (4G) services and applications grow. The major challenges are the risks involved with high investment and the possibility of getting it obsolete as the technology keeps on changing. However, the opportunities for wireless and mobile backhaul equipment market are immense, as numbers of cell sites and wireless broadband are expected to grow in next few years.

The global wireless and mobile backhaul equipment market is expected to be worth US$38.0 billion by 2014, growing at an estimated CAGR of 18.7% from 2009 to 2014. Asia is the largest wireless backhaul market; and is expected to be worth US$12.2 billion by 2014, accounting for nearly 32% of the total revenues. The Asian wireless backhaul market also has the highest CAGR of 21.8%.

Global wireless and mobile backhaul equipment market by technologies, 2009

Source: MarketsandMarkets

Microwave backhaul technology is expected to form the largest market in 2009. This market is expected to account for 43% of the total backhaul technology market. This is mainly because of its use in European and Asian market on a large scale. TDM & ATM accounts for the second largest market as American market is still dominated by this technology only.

Our analysis indicates that companies offering technology that will reduce operational cost (OPEX) cost and simultaneously enhance the network performance will have an edge over competitors. Agreements and collaborations as well as new product launches are the most popular strategies adopted by market players to stay ahead of the competition and to expand into new geographies. The key players in wireless and mobile backhaul equipment market include Cisco Systems, DragonWave Inc, Embarq, Huawei, Nokia Siemens, Sprint Nextel, Ceragon and Ericssion.

Original Source: wireless backhaul equipment market

Buy Now: wireless backhaul equipment market

Original Source: stem cell market

Buy Now: stem cell market

Report Description

The stem cell market is growing rapidly due to increasing regulatory approval and public acceptance bodies. The benefits of stem cell therapy are attracting an increasing number of patients. The product submarket for human and embryo stem cells are expected to drive the growth of the overall market. In addition, intensive R&D efforts and the increasing investments into research on stem cells therapy are soon expected to improve the efficacy of stem cell treatment. However, the high cost of the therapy may affect market growth.

The global stem cell market is estimated to be $88.3 billion by 2014, growing at a CAGR of 14.8 % from 2009 to 2014. The U.S. currently holds a 60% share of the global stem cell market; and forms an especially lucrative market for areas such as bone marrow transplantation through stem cells. This research report will help stakeholders gain a better understanding of product pricing and regulatory framework governing the dynamics of the stem cell market. The key players in the market include Osiris Therapeutics, Stem Tronix Inc., Stemcell Technologies, Genzyme Corp., Cytori, and Geron.

Market Estimates and Forecasts

The report categorizes the global stem cell market as follows:

• Stem Cell Products (adult stem cell, human embryonic stem cell, and other stem cell types)
• Stem Cell Services (stem cell banking, stem cell acquisition and testing, drug discovery and target identification, isolation/characterization services, and molecular biology )
• Stem Cell Technologies (stem cell acquisition, stem cell production, cryopreservation, and expansion and subculture)
• Stem Cell Applications (regenerative medicine – neurological disorders, orthopedics, cancer, hematological disorders, myocardial infarction and cardiovascular diseases, injuries, diabetes, liver disorder, incontinence, and drug development)

Each section will provide market data, market drivers, trends and opportunities, top-selling products, key players, and competitive outlook. This report will also provide market tables for various geographic regions covering the sub-segments and micro-markets. In addition, the report also provides more than 35 company profiles for each of its sub-segments.

What makes our reports unique?

• We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5.
• We provide 10% customization. Normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.
• We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.
• Comprehensive market analysis for the following sectors:

Pharmaceuticals, Medical Devices, Biotechnology, Semiconductor and Electronics, Energy and Power Supplies, Food and Beverages, Chemicals, Advanced Materials, Industrial Automation, and Telecom and IT. We also analyze retailers and super-retailers, technology providers, and research and development (R&D) companies.

Key questions answered

• Which are the high-growth segments/cash cows and how is the market segmented in terms of applications, products, services, ingredients, technologies, and stakeholders?
• What are market estimates and forecasts; which markets are doing well and which are not?
• Where are the gaps and opportunities; what is driving the market?
• Which are the key playing fields? Which are the winning edge imperatives?
• How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?

Powerful Research and analysis

The analysts working with MarketsandMarkets come from renowned publishers and market research firms, globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We, at MarketsandMarkets, are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.

Original Source: stem cell market

Buy Now: stem cell market

Global Stem Cell and Advanced Technologies Market

The stem cell market is growing rapidly due to increasing regulatory approval and public acceptance bodies. The benefits of stem cell therapy are attracting an increasing number of patients. The product submarket for human and embryo stem cells are expected to drive the growth of the overall market. In addition, intensive R&D efforts and the increasing investments into research on stem cells therapy are soon expected to improve the efficacy of stem cell treatment. However, the high cost of the therapy may affect market growth.

The global stem cell market is estimated to be $88.3 billion by 2014, growing at a CAGR of 14.8 % from 2009 to 2014. The U.S. currently holds a 60% share of the global stem cell market; and forms an especially lucrative market for areas such as bone marrow transplantation through stem cells. This research report will help stakeholders gain a better understanding of product pricing and regulatory framework governing the dynamics of the stem cell market. The key players in the market include Osiris Therapeutics, Stem Tronix Inc., Stemcell Technologies, Genzyme Corp., Cytori, and Geron.

 

Estimated size of stem cell market in 2009

 

Original Source: stem cell market

Buy Now: stem cell market

Table of contents

Executive summary
MARKET OVERVIEW
Stem cell market dynamics
OPPORTUNITIES
Stem cells product market
OPPORTUNITIES
Stem cells technology market
Stem cells services market
Stem cells applications market
Geographic analysis
Competitive landscape

1. INTRODUCTION
1.1. KEY TAKE-AWAYS
1.2. REPORT DESCRIPTION
1.3. Research METHODOLOGY
1.4. STAKEHOLDERS

2. Summary

3. market overview
3.1. Defining the stem cell market
3.2. Factors influencing the stem cells market
3.3. Stem cell market inhibitors
3.4. Regenerative medicine dominates stem cell applications
3.5. FACTORS INFLUENCING THE STEM CELLS MARKET
3.5.1. U.S. Liberal Politics
3.5.2. Guidelines for responsible stem cells research
3.5.3. European national policies and legal issues
3.5.4. E.U. funding for stem cells research
3.5.5. Asia Pacific
3.6. Stem cell patent analysis

4. Stem cell market dynamics
4.1. Drivers
4.1.1. Potential of stem cells in regenerative medicine
4.1.2. Key to anti-ageing and prolonging life
4.1.3. Increasing R&D INVESTMENTS in adult stem cell research
4.1.4. EASE of administration
4.1.5. Reduced risk of tissue rejection in transplants
4.1.6. Federal funding for stem cell research
4.2. Restraints
4.2.1. safety issues
4.2.2. Ethical issueS
4.2.3. minimal Insurance coverage
4.3. Opportunities
4.3.1. technological innovations
4.3.2. Emerging application as a drug discovery tool
4.3.3. other promising applications

5. Global stem cells product market
5.1. Stem cell classification on the basis of potency
5.2. Adult stem cells
5.2.1. Drivers
5.2.1.1. Applications in cancer and chronic disease treatment
5.2.1.2. Availability of adequate safety & efficacy evidence
5.2.1.3. Technology innovations
5.2.1.4. Lower costs & no ethical issues
5.2.2. Restraints & Opportunities
5.2.2.1. Lower therapeutic potential
5.2.2.2. Need for minimising intervention
5.2.3. Hematopoietic Stem Cells
5.2.3.1. Drivers & Restraints
5.2.3.1.1. Wide range of applications
5.2.3.1.2. Enhanced usage due to recent technology advancements
5.2.3.1.3. Underused treatment, ineffective GvHD management
5.2.4. Mesenchymal stem cells
5.2.4.1. Drivers
5.2.4.1.1. Huge potential of MSCs
5.2.4.1.2. Advantageous cell type for allogenic transplantation
5.2.4.2. Restraints & Opportunities
5.2.4.2.1. Low number of mesenchymal stem cells in bone marrow
5.2.4.3. Potential applications of MSC therapy
5.3. Embryonic stem cells
5.3.1. Drivers & REStraints
5.3.1.1. Immense potential due to pluripotent nature
5.3.1.2. Ban on federal funding lifted
5.3.1.3. Ethical issues and inadequate safety data
5.3.2. Umbilical cord stem cells
5.3.3. Neuronal stem cells
5.3.4. Dental stem cells
5.3.5. Other novel cell types

6. stem cells technology market
6.1. Stem cell production
6.1.1. Somatic nuclear transfer / Therapeutic cloning
6.1.2. IVF (In vitro fertilization)
6.1.3. Isolation & Cell culture
6.2. Expansion & Sub culture
6.3. Stem cell acquisition
6.3.1. Bone marrow harvest
6.3.2. Apheresis
6.3.3. Umbilical cord blood stem cells acquisition
6.4. Cryopreservation & storage

7. Global stem cells services market
7.1. Stem cell banking
7.1.1. Ethical issues on stem cell banking
7.2. Stem cell acquisition & testing
7.3. Characterization services
7.3.1. HLA typing services
7.3.2. Stem cell custom services
7.3.3. Stem cell custom antibody services
7.4. Molecular biology
7.5. Drug screening & target validation

8. Global stem cells applications market
8.1. Regenerative medicine
8.1.1. Drivers & Restraints
8.1.1.1. Simple and cost-effective production method
8.1.1.2. Public & political support
8.1.1.3. High cost of treatment and low reimbursements
8.1.2. Neurological disorders
8.1.2.1. Alzheimer’s disease
8.1.2.2. Parkinson’s disease
8.1.2.3. Multiple sclerosis
8.1.2.4. Others
8.1.3. Myocardial Infarction & cardiovascular diseases
8.1.4. Cancer
8.1.4.1. Breast cancer
8.1.4.2. Multiple myeloma
8.1.4.3. Other diseases
8.1.5. Injuries
8.1.6. Incontinence
8.1.7. Diabetes
8.1.8. Orthopedics
8.1.9. Liver disorders
8.1.10. Hematological disorders
8.1.10.1. Other applications
8.1.10.1.1. Limb Ischemia
8.1.10.1.2. Systemic lupus
8.2. Drug Discovery & Development

9. Geographic analysis
9.1. North America
9.2. Europe
9.3. Asia
9.4. ROW

10. Competitive landscape
Appendix
10.1. Government policies & guidelines
10.1.1. Patents for united states
10.1.2. Patents for europe
10.1.3. Patents for Japan

11. Company Profiles
11.1. Advanced Cell Technology Inc
11.2. Aldagen
11.3. Angel Biotechnology
11.4. Angioblast Systems Inc
11.5. Aastrom Biosciences Inc
11.6. Athersys
11.7. Bioheart Inc
11.8. Brainstorm Cell Therapeutics
11.9. California Stem Cell
11.10. Celgene Corporation
11.11. Cellartis AB
11.12. Cellerant Therapeutics
11.13. Cellular Dynamics International, Inc
11.14. Cellular Engineering Technologies
11.15. CordLife Ltd
11.16. Cytori Therapeutics Inc
11.17. ES Cell International
11.18. Gamida Cell Ltd
11.19. Genzyme Corporation
11.20. Geron Corporation Inc
11.21. Global Stem Inc
11.22. Intercytex (and its subsidiary Axordia)
11.23. Medistem Inc
11.24. Mesoblast Ltd
11.25. MultiCell Technologies, Inc
11.26. Neostem
11.27. Novocell Inc
11.28. NeuralStem Biopharmaceuticals, Ltd.
11.29. Opexa Therapeutics
11.30. Osiris Therapeutics, Inc
11.31. Plureon Corp
11.32. Pluristem Therapeutics
11.33. ReNeuron, Inc
11.34. StemCells, Inc
11.35. StemLifeLine
11.36. t2cure Gmbh
11.37. TheraVitae
11.38. Thermo Fisher Scientific Inc
11.39. Thermogenesis Corporation
11.40. VetCell Bioscience Ltd

List of TableS

SUMMARY TABLE  Global stem cell market 2009-2014 ($ thousands)
Table 1    Global stem cell market by product 2007-2014 ($ Millions)
Table 2    Global adult stem cell market by product 2007-2014 ($ Millions)
Table 3    Global other novel cell types market by product 2007-2014 ($ Millions)
Table 4    Global stem cell technology market 2007-2014 ($ Millions)
Table 5    Global stem cell production market by product 2007-2014 ($ Millions)
Table 6    Global stem cell acquisition market by product 2007-2014 ($ Millions)
Table 7    Global stem cell services market by product 2007-2014 $ Millions)
Table 8    Global characterization services market by product 2007-2014 ($ Millions)
Table 9    Global stem cell applications market by product  2007-2014 ($ Thousands)
Table 10 Global stem cell applications market by geography 2007-2014 ($ Millions)
Table 11 Global regenerative medicine market by product 2007-2014 ($ Millions)
Table 12 Global regenerative medicine market by geography 2007-2014 ($ Millions)
Table 13 Global neurological disorders market by geography  2007-2014 ($ Millions)
Table 14 Global Myocardial Infarction & cardiovascular diseases market by geography 2007-2014 ($ Millions)
Table 15 Global cancer market by geography 2007-2014 ($ Millions)
Table 16 Global Injuries market for stem cells by product 2007-2014 ($ Millions)
Table 17 Global Injuries market for stem cells by geography  2007-2014 ($ Millions)
Table 18 Global Incontinence market for stem cells by geography 2007-2014 ($ Millions)
Table 19 Global Diabetes  market by geography 2007-2014 ($ Millions)
Table 20 Global Orthopedics market in stem cells by geography 2007-2014 ($ Millions)
Table 21 Global Liver disorders market by geography 2007-2014 ($ Millions)
Table 22 Global Hematological disorders market by geography 2007-2014 ($ Millions)
Table 23 Global Other regenerative medicines market by geography 2007-2014 ($ Millions)
Table 24 Global Drug Discovery & Development market by geography 2007-2014 ($ Millions)
Table 28 New product, technology, service launch (2008-2009)
Table 29 List of agreements and collaborations (2008-2009)
Table 30 List of mergers and acquisition (2008-2009)

List of FIGURES

Figure 1 STEM CELL MARKET SEGMENTATION
Figure 2 Driving factors
Figure 3 Inhibitor matrix
Figure 4 Stem cell application market dynamics
Figure 5 RELATIVE IMPORTANCE OF FACTORS AFFECTING STEM CELL MARKET
Figure 6 NIH funding for stem cell research
Figure 7 patent analysis by geography 2006 to 2008
Figure 8 Patent analysis by segment 2006 to 2008
Figure 9 Patent analysis by competitors
Figure 10 Major market growth factors
Figure 11 Stem cell classification on the basis of potency
Figure 12 Stem cell technologies
Figure 13 Prominent focus areas in regenerative medicine
Figure 14 Stem cell transplants types
Figure 15 global Stem cells market by geography ($billion)
Figure 16 North American Stem cells market
Figure 17 european Stem cells market
Figure 18 asian Stem cells market
Figure 19 row Stem cells market
Figure 20 Major segments focused by global stem cell market players (2008-2009)
figure 21 Competitive landscape for collaborations (2008-2009)

Original Source: stem cell market

Buy Now: stem cell market

Original Source: Biodiesel market

Buy Now: Biodiesel market

KEY TAKE AWAYS

• To define the global market for Global Biodiesel market
• To measure the market size for the Global Biodiesel market and its sub-markets
• To identify the major driving factors and inhibitors
• To analyze the trends and forecasts of the main market and its segments
• To identify the major stakeholders in the market and draw a competitive landscape for the market leaders
• To analyze the trends and opportunities in major regions, viz. U.S, Europe, and Asia.

Report Description

Energy is one of the prime needs of mankind and several sources have been identified to meet this need. Petroleum had been the major source of energy for till date. But their limited availability and their surging prices have forced mankind to search for alternative fuels. Biodiesel had been one of the renewable fuels that have been developed and is contributing towards meeting the global demand for fuels. Biodiesel is renewable and is also independent of the price fluctuations in the conventional petroleum products. Another major advantage of Biodiesel is that they do not pollute the environment, in contrast to the non-renewable sources like petroleum. With the government of all the major nations taking initiatives to encourage the increasing usage of Biodiesel, this market is slated for a huge growth in the next few years. The surging prices for non-renewable source, petroleum in particular and growing concern over pollution-control is also helping the market for Biodiesel. Many countries have initiated blending of conventional diesel with some percentage of Biodiesel to enhance engine life and reduce pollution. With a huge opportunity in sight, companies are buzzing with huge investment in improving the conversion efficiency for the renewable sources and this will give the overall market a boost.

MARKETS COVERED

The major feedstocks like vegetable oils, Wasted Vegetable Oils, Algae and animal fats have been covered in great depth. We have also included in our report the various conversion processes like Transesterification, neutralization, phase separation, and purification. We have also included the different comparative analysis between conventional petroleum and Biodiesel. The various applications like automotive, aerospace, railways and heating have been extensively covered in our report. Each of the major and micro market includes detailed analysis of the market trends and forecast, affecting factors and their competitive landscape. We have done an in-depth geographic analysis for each of the markets and their sub-segments, covering the major regional markets, viz. U.S, Europe, Asia and Rest of the World.

STAKEHOLDERS

The intended audience of this report includes:

• Biodiesel producers
• Feedstock suppliers
• Automotive manufacturers
• Aerospace companies and organizations
• Research labs

Original Source: Biodiesel market

Buy Now: Biodiesel market

Table of Contents

1. Introduction
2. Summary
3. Market Overview
3.1. Evolution of Biodiesel
3.2. Market definitions
3.3. Factors affecting the market and their impact analysis
3.4. Pricing trend analysis for Biodiesel

4. Types of biofuels
4.1. Biogas
4.2. Vegetable oils
4.3. Biodiesel
4.4. Syngas
4.5. Bioethanol
4.6. Fischer-Tropsch diesel
4.7. Bio-DME
4.8. DMF
4.9. Biomethanol
4.10. Biohydrogen
4.11. Wood diesel
4.12. Mixed alcohol
4.13. Others

5. Production of Biodiesel
5.1. Challenges with Biodiesel production
5.1.1. Land availability
5.1.2. Climatic issues
5.1.3. Technology developments
5.1.4. Government policies
5.2. Conversion steps from bio-oil to Biodiesel
5.2.1. Transesterification
5.2.2. Neutralization
5.2.3. Phase separation
5.2.4. Purification
5.3. Feedstocks
5.3.1. Vegetable oils
5.3.2. Waste Vegetable Oils
5.3.3. Animal fats
5.3.4. Algae
5.3.5. Others

6. Consumption of Biodiesel
6.1. Global petroleum demand trends and forecast analysis
6.2. Consumption trends and forecasts of Biodiesel
6.3. Blends with conventional diesel

7. Biodiesel Vs Conventional petroleum
7.1. Pricing
7.2. Environmental pollution
7.3. Energy output
7.4. Production capacities
7.5. Production costs
7.6. Government benefits and initiatives

8. Applications
8.1. Automotive
8.2. Aerospace
8.3. Railways
8.4. Heating
8.5. Others

9. Geographic Analysis
9.1. United States
9.1.1. Production trends and forecast of Biodiesel
9.1.2. Consumption trends and forecast of Biodiesel
9.1.3. Government initiatives to encourage Biodiesel
9.1.4. Government taxes and subsidization
9.1.5. Price difference between Biodiesel and conventional diesel
9.1.6. Supply Vs. Demand
9.2. Germany
9.2.1. Production trends and forecast of Biodiesel
9.2.2. Consumption trends and forecast of Biodiesel
9.2.3. Government initiatives to encourage Biodiesel
9.2.4. Government taxes and subsidization
9.2.5. Price difference between Biodiesel and conventional diesel
9.2.6. Supply Vs. Demand
9.3. France
9.3.1. Production trends and forecast of Biodiesel
9.3.2. Consumption trends and forecast of Biodiesel
9.3.3. Government initiatives to encourage Biodiesel
9.3.4. Government taxes and subsidization
9.3.5. Price difference between Biodiesel and conventional diesel
9.3.6. Supply Vs. Demand
9.4. Italy
9.4.1. Production trends and forecast of Biodiesel
9.4.2. Consumption trends and forecast of Biodiesel
9.4.3. Government initiatives to encourage Biodiesel
9.4.4. Government taxes and subsidization
9.4.5. Price difference between Biodiesel and conventional diesel
9.4.6. Supply Vs. Demand
9.5. United Kingdom
9.5.1. Production trends and forecast of Biodiesel
9.5.2. Consumption trends and forecast of Biodiesel
9.5.3. Government initiatives to encourage Biodiesel
9.5.4. Government taxes and subsidization
9.5.5. Price difference between Biodiesel and conventional diesel
9.5.6. Supply Vs. Demand
9.6. Brazil
9.6.1. Production trends and forecast of Biodiesel
9.6.2. Consumption trends and forecast of Biodiesel
9.6.3. Government initiatives to encourage Biodiesel
9.6.4. Government taxes and subsidization
9.6.5. Price difference between Biodiesel and conventional diesel
9.6.6. Supply Vs. Demand
9.7. Asia-Pacific
9.7.1. Production trends and forecast of Biodiesel
9.7.2. Consumption trends and forecast of Biodiesel
9.7.3. Government initiatives to encourage Biodiesel
9.7.4. Government taxes and subsidization
9.7.5. Price difference between Biodiesel and conventional diesel
9.7.6. Supply Vs. Demand
9.8. India-China
9.8.1. Production trends and forecast of Biodiesel
9.8.2. Consumption trends and forecast of Biodiesel
9.8.3. Government initiatives to encourage Biodiesel
9.8.4. Government taxes and subsidization
9.8.5. Price difference between Biodiesel and conventional diesel
9.8.6. Supply Vs. Demand
9.9. Rest of EU nations
9.9.1. Production trends and forecast of Biodiesel
9.9.2. Consumption trends and forecast of Biodiesel
9.9.3. Government initiatives to encourage Biodiesel
9.9.4. Government taxes and subsidization
9.9.5. Price difference between Biodiesel and conventional diesel
9.9.6. Supply Vs. Demand
9.10. Canada-Mexico
9.10.1. Production trends and forecast of Biodiesel
9.10.2. Consumption trends and forecast of Biodiesel
9.10.3. Government initiatives to encourage Biodiesel
9.10.4. Government taxes and subsidization
9.10.5. Price difference between Biodiesel and conventional diesel
9.10.6. Supply Vs. Demand
9.11. Rest of the World
9.11.1. Production trends and forecast of Biodiesel
9.11.2. Consumption trends and forecast of Biodiesel
9.11.3. Government initiatives to encourage Biodiesel
9.11.4. Government taxes and subsidization
9.11.5. Price difference between Biodiesel and conventional diesel
9.11.6. Supply Vs. Demand

10. Company Profiles
10.1. Ag Environmental Products, LLC
10.2. Archer Daniels Midland Company
10.3. ADM Hamburg AG
10.4. Ag Environmental Products, LLC
10.5. Archer Daniels Midland Company
10.6. ADM Hamburg AG
10.7. BDI BioDiesel International AG
10.8. Biodiesel Industries, Inc.
10.9. Environmental Alternatives LLC
10.10. Flint Hills Resources LP
10.11. Green Star Products, Inc.
10.12. American Biofuels
10.13. Griffin Industries
10.14. OceanAir Environmental LLC
10.15. Oelmuhle Hamburg AG
10.16. Organic Fuels LLC
10.17. Pacific Biodiesel, Inc.
10.18. Petroplus Holdings AG
10.19. Renewable Energy Group
10.20. Stepan Company
10.21. Topia Energy, Inc.
10.22. VERBIO Diesel Bitterfeld GmbH & Co. KG.
10.23. World Energy Alternatives

11. Patents
11.1. U.S Patents
11.2. EU Patents
11.3. Asia Patents

Original Source: Biodiesel market

Buy Now: Biodiesel market

Wilmington, Del.- The Healthcare practice at MarketsandMarkets is pleased to announce its Analyst Briefing Presentation on the Opportunity Analysis- H1N1 (Swine Flu) Vaccination Market (2009-2012) to be held on 3rd Nov 2009

The pandemic outbreak of the influenza opened the gates for the drugs such as Tamiflu in the initial phase for the curing of the disease but the following phase will see a shift from curing to prevention.  Thus, arise the requirement for the vaccine for the treatment of H1N1. H1N1 vaccine market is the forecast for the upcoming vaccines for the prevention of the disease among the unaffected population. The vaccines market is classified for the intramuscular vaccines and intranasal vaccines. Intramuscular will cater 80-85% of market revenues and the remaining will be tapped by the intranasal vaccines. The initial lot of vaccines will be of egg based and cell based manufacturing. The market forecast is from late 2009 as the first lot of doses are expected to be rolled out in the first week of October 2009.

The first movers of the in the vaccines market are Glaxo Smith Kline (GSK), Novartis, CSL, Medimmune, Baxter, Sinovec and Sanofi Pastuer. Medimmune is the only producer of the intranasal vaccine whereas other companies are expected to come out with intramuscular vaccines. The companies have got approvals for their first lots from the governments of the various countries such as U.S., U.K., France, China, Denmark and Australia. The involvement of government bodies, increased awareness about prevention and pandemic situation of the influenza is driving the market for the vaccines.

Due to intensive ongoing research and technology introduction, the market players are compelled to understand the market dynamics, innovations,  pricing, products, marketing and regulatory framework of the market.

The global H1N1 Influenza vaccine market is estimated to be of 676 million in 2009 with first lot of doses being commercialized on 30th September’ 2009. The market will see a high CAGR for the next two years i.e. the market is expected to be at $7.03 billion in 2011 with a CAGR of 222.4% from 2009 to 2011. However, the very high CAGR will settle down by 2012 to 30% for the period of 2009 to 2012. The reason for the sudden settle down of the growth is that it is expected that most of the world population will be immunized by the end of 2011.

To register your participation, please click here
http://www.marketsandmarkets.com/AnalystBriefing/swine-Flu-vaccination-market.asp
MarketsandMarkets is a research and consulting firm that publishes 120 market research reports per year. Each strategically analyzed report contains in-depth, five-level segmentation for each of the products, services, applications, technologies, ingredients and stakeholders categories. Our reports also analyze about 200 patents, over 40 companies and micro markets that are mutually exclusive and collectively exhaustive. Browse all our 120 titles at www.marketsandmarkets.com.

Ms. Sunita
108, West 13th Street,
Wilmington
DE, 19801
County of New Castle
Tel: +1-888-989-8004
Email: sales@marketsandmarkets.com

H1N1 Influenza A (2009) is the first pandemic influenza of 21^st century affecting more than more than four lac people in more than 180 countries across the globe in 2009.  The flu broke in Mexico in the month of March and then affected U.S. and after that it spread across the globe.  H1N1 (2009) influenza have a mutation of pig, bird and humans which has made it more dangerous and fatal compared to previous occurrence of H1N1 (1918).

Review the complete report at: http://www.marketsandmarkets.com/PressReleases/swine-Flu-vaccination-market.asp

The pandemic outbreak of the influenza opened the gates for the drugs such as Tamiflu in the initial phase for the curing of the disease but the following phase will see a shift from curing to prevention.  Thus, arise the requirement for the vaccine for the treatment of H1N1. H1N1 vaccine market is the forecast for the upcoming vaccines for the prevention of the disease among the unaffected population. The vaccines market is classified for the intramuscular vaccines and intranasal vaccines. Intramuscular will cater 80-85% of market revenues and the remaining will be tapped by the intranasal vaccines. The initial lot of vaccines will be of egg based and cell based manufacturing. The market forecast is from late 2009 as the first lot of doses are expected to be rolled out in the first week of October 2009.

The first movers of the in the vaccines market are Glaxo Smith Kline (GSK), Novartis, CSL, Medimmune, Baxter, Sinovac and Sanofi Pastuer. Medimmune is the only producer of the intranasal vaccine whereas other companies are expected to come out with intramuscular vaccines. The companies have got approvals for their first lots from the governments of the various countries such as U.S., U.K., France, China, Denmark and Australia. The involvement of government bodies, increased awareness about prevention and pandemic situation of the influenza is driving the market for the vaccines.

Due to intensive ongoing research and technology introduction, the market players are compelled to understand the market dynamics, innovations,  pricing, products, marketing and regulatory framework of the market.

The global H1N1 Influenza vaccine market is estimated to be of 676 million in 2009 with first lot of doses being commercialized on 30^th September’ 2009. The market will see a high CAGR for the next two years i.e. the market is expected to be at $7.03 billion in 2011 with a CAGR of 222.4% from 2009 to 2011.

About MarketsandMarkets

MarketsandMarkets is a research and consulting firm that publishes 120 market reports per year. Each strategically analyzed report contains in-depth, five-level segmentation for each of the products, services, applications, technologies, ingredients and stakeholders categories. Our reports also analyze about 200 patents, over 40 companies and micro markets that are mutually exclusive and collectively exhaustive. Browse all our 120 titles at www.marketsandmarkets.com.

Contact:
Ms. Sunita
108, West 13th Street,
Wilmington
DE, 19801
County of New Castle
Tel: +1-888-989-8004
Email: sales@marketsandmarkets.com

A new market research report, ‘Global H1N1 2009 Influenza Vaccine’, published by MarketsandMarkets (www.marketsandmarkets.com) analyzes the global H1N1 2009 Influenza vaccine market over the period 2009-2012. The report studies the major market drivers, restraints, and opportunities for global H1N1 (Swine Flu) Influenza vaccine market and also evaluates the major pandemic trends with respect to different geographic regions.

Browse in-depth TOC on stem cell market. Early buyers will receive 10% customization of report.
http://www.marketsandmarkets.com/Market-Reports/influenza-vaccines-market-159.html

The global H1N1 2009 Influenza vaccine market is estimated to be $7,028 billion by 2011, growing at a CAGR of 222.4 % from 2009 to 2011. Some of the key players in this market are GlaxoSmithKline, Novartis, CSL, MedImmune, Sanofi-Pasteur, Solvay, Sinovac Biotech and Hualun Biologicals.

The global H1N1 2009 Influenza vaccine market is growing due to the prevailing pandemic of H1N1 influenza and huge demand from different countries for the vaccines against it. The H1N1 Influenza vaccine market is mainly driven by the increasing awareness of the population, global spread of H1N1 influenza and the initiatives taken by government & other public institutions for immunization of the population against H1N1 influenza. The North America region is the current lucrative market for H1N1 influenza vaccines with other regions also having high infection rate across the population.

Due to intensive ongoing research and technology introduction, the market players are compelled to understand the market dynamics, innovations,  pricing, products, marketing and regulatory framework of the market.

SCOPE AND FORMAT

This report will enable strategic understanding and opportunities in the H1N1 2009 influenza vaccines market. The report covers the following market segments.

Vaccines Markets: Intramuscular Vaccines and Intranasal vaccines.

Geography Markets: North America, Europe, Asia-Pacific and ROW

Each section of the report offers market data with respect to segments and geography. It also provides market trends with respect to drivers, restraints and opportunities. The report contains strategic section with respect to competitive landscape and market overview. The report will encompass around 15 company profiles.

Analyst Briefings on 27th  Oct 2009
The Healthcare practice at MarketsandMarkets is pleased to announce its Analyst Briefing Presentation on the Opportunity Analysis- H1N1 (Swine Flu) Vaccination Market (2009-2012) to be held on 27th Oct 2009

To register your participation, please click here
http://www.marketsandmarkets.com/AnalystBriefing/swine-Flu-vaccination-market.asp

Contact our representative to sponsor this report

About MarketsandMarkets

MarketsandMarkets is a research and consulting firm that publishes 120 market research reports per year. Each strategically analyzed report contains in-depth, five-level segmentation for each of the products, services, applications, technologies, ingredients and stakeholders categories. Our reports also analyze about 200 patents, over 40 companies and micro markets that are mutually exclusive and collectively exhaustive. Browse all our 120 titles at www.marketsandmarkets.com.
Contact:
Ms. Sunita
108, West 13th Street,
Wilmington
DE, 19801
County of New Castle
Tel: +1-888-989-8004
Email: sales@marketsandmarkets.com

Original Source: H1N1 InfluenzaVaccine Market

Buy Now: H1N1 InfluenzaVaccine Market

H1N1 Influenza A (2009) is the first pandemic influenza of 21^st century affecting more than more than four lac people in more than 180 countries across the globe in 2009.  The flu broke in Mexico in the month of March and then affected U.S. and after that it spread across the globe.  H1N1 (2009) influenza have a mutation of pig, bird and humans which has made it more dangerous and fatal compared to previous occurrence of H1N1 (1918).

The pandemic outbreak of the influenza opened the gates for the drugs such as Tamiflu in the initial phase for the curing of the disease but the following phase will see a shift from curing to prevention.  Thus, arise the requirement for the vaccine for the treatment of H1N1. H1N1 vaccine market is the forecast for the upcoming vaccines for the prevention of the disease among the unaffected population. The vaccines market is classified for the intramuscular vaccines and intranasal vaccines. Intramuscular will cater 80-85% of market revenues and the remaining will be tapped by the intranasal vaccines. The initial lot of vaccines will be of egg based and cell based manufacturing. The market forecast is from late 2009 as the first lot of doses are expected to be rolled out in the first week of October 2009.

The first movers of the in the vaccines market are Glaxo Smith Kline (GSK), Novartis, CSL, Medimmune, Baxter, Sinovec and Sanofi Pastuer. Medimmune is the only producer of the intranasal vaccine whereas other companies are expected to come out with intramuscular vaccines. The companies have got approvals for their first lots from the governments of the various countries such as U.S., U.K., France, China, Denmark and Australia. The involvement of government bodies, increased awareness about prevention and pandemic situation of the influenza is driving the market for the vaccines.

Due to intensive ongoing research and technology introduction, the market players are compelled to understand the market dynamics, innovations,  pricing, products, marketing and regulatory framework of the market.

The global H1N1 Influenza vaccine market is estimated to be of 676 million in 2009 with first lot of doses being commercialized on 30^th September’ 2009. The market will see a high CAGR for the next two years i.e. the market is expected to be at $7.03 billion in 2011 with a CAGR of 222.4% from 2009 to 2011. However, the very high CAGR will settle down by 2012 to 30% for the period of 2009 to 2012. The reason for the sudden settle down of the growth is that it is expected that most of the world population will be immunized by the end of 2011.

Market estimates and forecast

This report will enable strategic understanding and opportunities in the H1N1 2009 influenza vaccines market. The report covers the following market segments.

Vaccines Markets: Intramuscular Vaccines and Intranasal vaccines.

Geography Markets: North America, Europe, Asia-Pacific and ROW

Each section of the report offers market data with respect to segments and geography. It also provides market trends with respect to drivers, restraints and opportunities. The report contains strategic section with respect to competitive landscape and market overview. The report will encompass around 15 company profiles

What makes our reports unique?

• We provide the longest market segmentation chain in this industry- not many reports provide market breakdown upto level 5.
• We provide 10% customization. Normally it is seen that clients do not find specific market intelligence that they are looking for. Our customization will ensure that you necessarily get the market intelligence you are looking for and we get a loyal customer.
• We conduct detailed market positioning, product positioning and competitive positioning. Entry strategies, gaps and opportunities are identified for all the stakeholders.
• Comprehensive market analysis for the following sectors:
• Pharmaceuticals, Medical Devices, Biotechnology, Semiconductor and Electronics, Energy and Power Supplies, Food and Beverages, Chemicals, Advanced Materials, Industrial Automation, and Telecom and IT. We also analyze retailers and super-retailers, technology providers, and research and development (R&D) companies.

Key questions answered

• Which are the high-growth segments/cash cows and how is the market segmented in terms of applications, products, services, ingredients, technologies, and stakeholders?
• What are market estimates and forecasts; which markets are doing well and which are not?
• Where are the gaps and opportunities; what is driving the market?
• Which are the key playing fields? Which are the winning edge imperatives?
• How is the competitive outlook; who are the main players in each of the segments; what are the key selling products; what are their strategic directives, operational strengths and product pipelines? Who is doing what?

Powerful Research and analysis

The analysts working with MarketsandMarkets come from renowned publishers and market research firms, globally, adding their expertise and domain understanding. We get the facts from over 22,000 news and information sources, a huge database of key industry participants and draw on our relationships with more than 900 market research companies across the world. We, at MarketsandMarkets, are inspired to help our clients grow by providing qualitative business insights with our huge market intelligence repository.

Original Source: H1N1 InfluenzaVaccine Market

Buy Now: H1N1 InfluenzaVaccine Market

Table of Content

1. Introduction
1.1. Key Take Aways
1.2. Report Description
1.3. SCOPE AND FORMAT
1.4. STAKEHOLDERS

2. Summary
2.1. Research Methodology

3. Market Overview
3.1. Past Pandemic Influenzas
3.1.1. 1918 Spanish Influenza Pandemic:
3.1.1.1. 1957 – Asian Flu
3.1.1.2. 1968 – Hong Kong Flu
3.1.2. Present Pandemic H1N1 Influenza
3.1.2.1. H1n1 Pandemic life cycle
3.1.2.2. Consumer insights
3.1.2.2.1. Awareness about the vaccines
3.1.2.2.2. Availability of vaccines
3.1.2.2.3. Cost of vaccines
3.1.2.2.4. Proximity of vaccine centre
3.1.2.2.5. Type of vaccine available (intramuscular / intranasal)
3.1.2.2.6. Availability of drugs/substitute treatment
3.1.2.2.7. Personal health condition
3.1.2.2.8. Side-effects
3.1.3. SUMMARY

4. Global H1N1 2009 Influenza vaccine Market
4.1. Market Overview
4.1.1. Industry Life Cycle for H1N1 Vaccine Market
4.1.2. Priority Groups for the H1N1 vaccines
4.1.3. Priority 1
4.1.4. Priority 2
4.1.5. Priority 3
4.1.6. Priority 4
4.1.7. Priority 5
4.1.8. Priority 6
4.2. Drivers
4.2.1. Increasing awareness about the pandemic Influenza (H1N1) 2009 driving the market
4.2.2. Being Proactive- Need of the hour
4.2.3. Government and Public INSTITUTIONS INITIATIVES
4.2.4. Source for increasing Revenue
4.3. Restraints
4.3.1. High cost Involvement
4.3.2. Lengthy manufacturing process
4.3.3. Lucrative Oligopoly market scenario
4.4. Opportunities
4.4.1. Shift in manufacturing from Egg-based to cell based technology
4.4.2. Opportunity for emerging economies through Mergers and Acquisitions
4.4.3. Market for Adjuvants
4.5. Global H1N1 2009 Vaccines Market, by product
4.5.1. Pricing of Pandemic Influenza Vaccines
4.5.2. Manufacturing Process of Influenza Vaccines
4.5.2.1. Egg- based Manufacturing:
4.5.2.2. Cell-based Manufacturing:
4.5.2.3. Recombinant Technology
4.6. Global Market for Intramuscular Vaccine, By Geography
4.6.1. Drivers:
4.6.1.1. Easy availability is boosting the demand
4.6.1.2. Less risky
4.6.1.3. Caters to large segment of population
4.6.1.4. Cost effective
4.6.2. Restraints:
4.6.2.1. Rates low on User- friendly scale
4.7. Global Market for Intranasal Vaccine, By Geography
4.7.1. Drivers:
4.7.1.1. User Friendly administration of intranasal vaccine is increasing its application
4.7.1.2. Thimerosal free vaccine
4.7.1.3. Advancement in technology of intranasal influenza vaccines
4.7.1.4. Insurance coverage
4.7.1.5. Improved Efficacy for children is giving a boost to intranasal vaccine market
4.7.1.6. Approval for refrigeration
4.7.2. Restraints:
4.7.2.1. High cost
4.7.2.2. Limited consumer segment
4.7.3. Benchmarking of Approved Vaccines (September 2009)
4.7.4. Pipeline Overview of H1N1 vaccines
4.7.4.1. CSL
4.7.4.2. Baxter
4.7.4.3. GlaxoSmithKline
4.7.4.4. Hualun Biologicals
4.7.5. Competitive Analysis
4.8. Summary:

5. Geographical analysis
5.1. Comparative analysis of global 2009 H1N1 influenza vaccine by geography
5.1.1. Healthcare Expenditure
5.1.2. Availability of H1N1 vaccines
5.1.3. H1N1 influenza spread
5.1.4. Government contracts
5.2. North America H1N1 Vaccine market
5.2.1. U.S.
5.2.2. mexico
5.2.3. Drivers & restraints
5.2.3.1. Governmental Support
5.2.3.2. Demographic status
5.2.3.3. Availability of drugs
5.3. Europe H1N1 Vaccine Market
5.3.1. FRANCE
5.3.2. GERMANY
5.3.3. Drivers & Restraints
5.3.3.1. High per capita healthcare expenditure
5.3.3.2. Potential Side-effects
5.4. Asia Pacific H1N1 Vaccine Market
5.4.1. AUSTRALIA
5.4.2. CHINA
5.4.3. JAPAN
5.4.4. INDIA
5.5. Rest Of World (ROW) H1N1 vaccine market
5.5.1. MIDDLE EAST

6. Appendix

7. Company Profiles
7.1. Baxter
7.2. Butantant Institute
7.3. Cantacuzino Institute
7.4. Changchun Institute of Biological products
7.5. Crucell N.V
7.6. CSL
7.7. Green cross
7.8. GSK
7.9. Hualan biological
7.10. Inovio Biomedical
7.11. Kitasato Institute
7.12. MedImmune
7.13. Merck & Co.
7.14. Novartis
7.15. Novavax
7.16. Omnivest Ltd.
7.17. Sanofi pasture
7.18. Shangai Institute of Biological Products
7.19. Sinovac
7.20. Solvay
7.21. Zhejiang Tianyuan-BioPharmaceutical Co. Ltd.

Original Source: H1N1 InfluenzaVaccine Market

Buy Now: H1N1 InfluenzaVaccine Market

Opportunity Analysis- H1N1 (Swine Flu) Vaccination Market (2009-2012)

H1N1 Influenza A (2009) is the first pandemic influenza of 21^st century affecting more than more than four lac people in more than 180 countries across the globe in 2009.  The flu broke in Mexico in the month of March and then affected U.S. and after that it spread across the globe.  H1N1 (2009) influenza have a mutation of pig, bird and humans which has made it more dangerous and fatal compared to previous occurrence of H1N1 (1918).

The pandemic outbreak of the influenza opened the gates for the drugs such as Tamiflu in the initial phase for the curing of the disease but the following phase will see a shift from curing to prevention.  Thus, arise the requirement for the vaccine for the treatment of H1N1. H1N1 vaccine market is the forecast for the upcoming vaccines for the prevention of the disease among the unaffected population. The vaccines market is classified for the intramuscular vaccines and intranasal vaccines. Intramuscular will cater 80-85% of market revenues and the remaining will be tapped by the intranasal vaccines. The initial lot of vaccines will be of egg based and cell based manufacturing. The market forecast is from late 2009 as the first lot of doses are expected to be rolled out in the first week of October 2009.

The first movers of the in the vaccines market are Glaxo Smith Kline (GSK), Novartis, CSL, Medimmune, Baxter, Sinovac and Sanofi Pastuer. Medimmune is the only producer of the intranasal vaccine whereas other companies are expected to come out with intramuscular vaccines. The companies have got approvals for their first lots from the governments of the various countries such as U.S., U.K., France, China, Denmark and Australia. The involvement of government bodies, increased awareness about prevention and pandemic situation of the influenza is driving the market for the vaccines.

Due to intensive ongoing research and technology introduction, the market players are compelled to understand the market dynamics, innovations,  pricing, products, marketing and regulatory framework of the market.

The global H1N1 Influenza vaccine market is estimated to be of 676 million in 2009 with first lot of doses being commercialized on 30^th September’ 2009. The market will see a high CAGR for the next two years i.e. the market is expected to be at $7.03 billion in 2011 with a CAGR of 222.4% from 2009 to 2011.

Estimated size of H1N1 Influenza Vaccine market in 2009

The target consumers of commercially-available baby food range from infants (babies aged 6 to 12 months) to toddlers (children up to three years old). Baby food is available in various flavors and in both solid and liquid form. Modern-day time constraints have reduced the use of homemade baby food in both developed as well as developing nations. While U.S. and Europe hold a major share of the global baby food market, emerging economies such as China, India, Brazil, Russia, and Romania also represent a high growth rate.

Review the complete report at: http://www.marketsandmarkets.com/Market-Reports/baby-food-global-market-75.html

The baby food market is getting a big boost from the increasing awareness about the role it plays in meeting the nutritional needs of infants and toddlers. The major challenges for the baby food industry are low birth rates, static market conditions in developed countries, and milk intolerance in babies. However, opportunities for the baby food market is immense, as there is large untapped market in developing economies and as evolving food technology and new product developments are expected to attract more customers in future.

The global baby food market is expected to be worth US$37.6 billion by 2014, growing at an estimated CAGR of 5.0% from 2009 to 2014. Bottled baby food forms the largest market segment; and is expected to reach US$9.9 billion by 2014 at a CAGR of 4.9% for the same period. The segment with the highest growth potential is expected to be frozen baby food followed by bottled baby food products and baby cereals. Nestlé SA is the market leader in the global baby food products market. The other key market players are H.J. Heinz, Bristol-Myers Squibb, DANONE and Hero.

The major segments in the baby food product market are baby cereals, bottled baby foods, frozen baby foods, baby snacks and soups. Companies are focusing mainly on developing easily digestible and competitively priced fortified baby food. Evolving food technologies are enabling the market players to offer quality products with enhanced benefits like optimum nutrients content for babies. The growth in the baby food market is primarily due to the increasing demand from the Asian countries.

The accompanying table indicates the estimated market size of baby food products in 2009. The market for bottled baby foods is expected to enjoy the maximum market share followed by the baby cereals. The patent analysis of baby food products indicates that maximum number of patents has been registered for bottled baby food, which accounts for 70% of the total number of patents registered. Baby cereals is second with 16%, followed by baby snacks with 12% of the total patents registered. Geography-wise, the U.S. accounts for 58% of the total patents registered in baby food products followed by Europe with 30%.

Contact our representative to sponsor this report

About MarketsandMarkets

MarketsandMarkets is a research and consulting firm that publishes 120 market research reports per year. Each strategically analyzed report contains 250 pages of valuable market data, including more than 100 market data summary tables and in-depth, five-level segmentation for each of the products, services, applications, technologies, ingredients and stakeholders categories. Our reports also analyze about 200 patents, over 50 companies and micro markets that are mutually exclusive and collectively exhaustive. Browse all our 120 titles at www.marketsandmarkets.com.

Contact:
Ms. Sunita
108, West 13th Street,
Wilmington
DE, 19801
County of New Castle
Tel: +1-888-989-8004
Email: sales@marketsandmarkets.com

The neurostimulation market is driven mainly by technology advancements, rising consumer awareness, rising age-related neurological disorders, improved clinical outcomes, long-term cost-effectiveness, increased FDA approvals for clinical trials, and the development of sophisticated implantable neurostimulation devices. Currently, there is a huge influx of new players entering into the market, thus leading to increased investments and R&D activities.

Browse complete report here: http://www.marketsandmarkets.com/Market-Reports/neurostimulators-advanced-technologies-and-global-market-102.html

The global market for neurostimulation products is expected to be worth $3.6 billion in 2009, and expected to reach $10.2 billion by 2014, driven by the multiple treatment applications of neurostimulation products, and the emergence of venture capital in the industry. Neurostimulation treatment involves less risk of infection, pain, bleeding, and swelling. These factors are encouraging an ever-increasing number of patients to opt for this treatment which is driving the market.

The neurostimulation market is driven mainly by technology advancements, rising consumer awareness, rising age-related neurological disorders, improved clinical outcomes, long-term cost-effectiveness, increased FDA approvals for clinical trials, and the development of sophisticated implantable neurostimulation devices. Currently, there is a huge influx of new players entering into the market, thus leading to increased investments and R&D activities.

The above figure illustrates the relative market shares and growth for the various neurostimulation applications in 2009. Alzheimer’s and Parkinson’s applications have relatively high market size and high growth rate, thereby promising huge potential market for the major market players. Pain, chronic heart failure, and the strokes applications markets have an average market share but relative high growth rate; and are thus witnessing increased number of new entrants. Obesity, others neurodisorders (incontinence and gastroparesis) applications currently have low market shares but very high growth rates; while the essential tremors and eye disorder applications have low market shares and low growth rates.

Contact our representative to sponsor this report

About MarketsandMarkets
MarketsandMarkets is a research and consulting firm that publishes 120 market reports per year. Each strategically analyzed report contains 250 pages of valuable market data, including more than 100 market data summary tables and in-depth, five-level segmentation for each of the products, services, applications, technologies, ingredients and stakeholders categories. Our reports also analyze about 200 patents, over 50 companies and micro markets that are mutually exclusive and collectively exhaustive.

Contact:
Ms. Sunita
108, West 13th Street,
Wilmington, DE, 19801
County of New Castle
Tel: +1-888-989-8004
Email: sales@marketsandmarkets.com